Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-26

Clinical Trial Update: Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous immunoglobulins for treating Multiple System Atrophy has been completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2015-10-26